Reduced breast cancer risk with increasing serum folate in a case-control study of the C677T genotype of the methylenetetrahydrofolate reductase gene

European Journal of Cancer

Volumn 40, Issue 8, 2004, Pages 1250-1254

  Beilby, J ^a   Ingram, D ^b   Hahnel R ^c   Rossi, E ^a  

^a Clinical Biochemistry   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Breast cancer; Folic acid; Methylenetetrahydrofolate reductase

Indexed keywords

METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; FAT INTAKE; FEMALE; FOLIC ACID BLOOD LEVEL; GENOTYPE; GEOMETRY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; PARITY; PRIORITY JOURNAL; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLIC ACID; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; RISK FACTORS;

EID: 1942455717     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2004.01.026     Document Type: Article

References (18)

1. Kim Y.I. Folate and carcinogenesis. evidence, mechanisms and implications J. Nutr. Biochem. 10:1999;66-68.
2. Ueland P.M., Hustad S., Schneede J., Refsum H., Vollset S.E. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol. Sci. 22:2001;195-201.
3. Ulvik A., Evensen E.T., Lien E.A.et al. Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am. J. Med. Genet. 101:2001;246-254.
4. Shrubsole M.J., Jin F., Dai Q.et al. Dietary folate intake and breast cancer risk. results from the Shanghai Breast Cancer Study Cancer Res. 61:2001;7136-7141.
5. Thorand B., Kohlmeier L., Simonsen N., Croghan C., Thamm M. Intake of fruits, vegetables, folic acid and related nutrients and risk of breast cancer in postmenopausal women. Public Health Nutr. 1:1998;147-156.
6. Zhang S., Hunter D.J., Hankinson S.E.et al. A prospective study of folate intake and the risk of breast cancer. JAMA. 281:1999;1632-1637.
7. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 350:1997;990-994.
8. Wilson D.H., Herrmann R., Hsu S.et al. Ion capture assay for folate with the Abbott analyser. Clin. Chem. 41:1995;1780-1781.
9. Frosst P., Blom H.J., Milos R.et al. A candidate genetic risk factor for vascular disease. a common mutation in methylenetetrahydrofolate reductase Nat. Genet. 10:1995;111-113.
10. Burge J.C., Chorban P., McKnight T., Kyler M.K., Flancbaum L. Urinary ammonia plus urea as an estimate of total urinary nitrogen in patients receiving parenteral nutrition support. JPEN. 17:1992;529-531.
11. Kelsey J.L. Breast cancer epidemiology. summary and future directions Epidemiol. Rev. 15:1993;256-263.
12. Longnecker M.P., Berlin J.A., Orza M.J., Chalmers T.C. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 260:1988;652-656.
13. Zhang S.M., Willett W.C., Selhub J.et al. Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer. J. Natl. Cancer Inst. 95:2003;373-380.
14. Rohan T.E., Jain M.G., Howe G.R., Miller A.B. Dietary folate consumption and breast cancer risk. J. Natl. Cancer Inst. 92:2000;266-269.
15. Wu K., Helzlsouer K.J., Comstock G.W., Hoffman S.C., Nadeau M.R., Selhub J. A prospective study on folate, B12, and pyridoxal 5′-phosphate (B6) and breast cancer. Cancer Epidemiol. Biomarkers Prev. 8:1999;209-217.
16. Semenza J.C., Delfino R.J., Ziogas A., Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat. 77:2003;217-223.
17. Campbell I.G., Baxter S.W., Eccles D.M., Choong D.Y. Methylenetetrahydrofolate reductase polymorphism and susceptibility to breast cancer. Breast Cancer Res. 4:2002;R14.
18. Sharp L., Little J., Schofield A.C.et al. Folate and breast cancer. the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) Cancer Lett. 181:2002;65-71.